Pre-existing comorbidities diminish the likelihood of seropositivity after sars-cov-2 vaccination

HIGHLIGHTS

  • who: Alok R. Amraotkar and collaborators from the Division of Environmental Medicine, Christina Lee Envirome Institute, Department of Medicine, University of Louisville School of Medicine, Louisville, KY, USA have published the Article: Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination, in the Journal: Vaccines 2022, 10, 1363. of /2022/
  • what: The aim was to compare the univariate relationship of chronic health conditions (CHCs) between seronegative versus seropositive statuses. Limitations of the study include a lack of SARS-CoV-2 titer or neutralization data, which were not the primary objective of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?